OBIO
FinancialsIn USD Thousands
Financials are currently not available.
| Period Ending: | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Total Revenue | $2,760 | $3,533 | -- | |
| Cost of Revenue | $186 | $211 | -- | |
| Gross Profit | $2,574 | $3,322 | -- | |
| Operating Expenses | ||||
| Research and Development | $33,822 | $21,945 | -- | |
| Sales, General and Admin. | $20,258 | $14,034 | $395 | |
| Non-Recurring Items | -- | -- | -- | |
| Other Operating Items | -- | -- | -- | |
| Operating Income | -$51,506 | -$32,657 | -$395 | |
| Add'l income/expense items | $2,386 | -$951 | $16 | |
| Earnings Before Interest and Tax | -$49,120 | -$33,608 | -$379 | |
| Interest Expense | -- | -- | -- | |
| Earnings Before Tax | -$49,120 | -$33,608 | -$379 | |
| Income Tax | -- | -- | -- | |
| Minority Interest | -- | -- | -- | |
| Equity Earnings/Loss Unconsolidated Subsidiary | -- | -- | -- | |
| Net Income-Cont. Operations | -$49,120 | -$33,608 | -$379 | |
| Net Income | -$49,120 | -$33,608 | -$379 | |
| Net Income Applicable to Common Shareholders | -$49,120 | -$33,608 | -$379 |
-
Summary -
Real-Time -
After-Hours -
Pre-Market -
Charts
-
News -
Press Releases
-
Dividend History -
Historical Quotes -
Historical NOCP -
Financials -
Earnings -
P/E & PEG Ratios -
Option Chain -
Short Interest -
Institutional Holdings -
Insider Activity -
SEC Filings -
Revenue EPS
%20Revenue%20EPS%20%7C%20Nasdaq&_biz_n=28&rnd=797588&cdn_o=a&_biz_z=1742719029755)
%20Pre-Market%20Quotes%20%7C%20Nasdaq&_biz_n=29&rnd=491044&cdn_o=a&_biz_z=1742719029756)
%20Pre-Market%20%7C%20Nasdaq&_biz_n=30&rnd=13504&cdn_o=a&_biz_z=1742719029756)
%20Financials%20%7C%20Nasdaq&_biz_n=31&rnd=375873&cdn_o=a&_biz_z=1742719029756)
%20Financials%20%7C%20Nasdaq&rnd=38178&cdn_o=a&_biz_z=1742719029761)